0001493152-22-015263.txt : 20220527 0001493152-22-015263.hdr.sgml : 20220527 20220527103722 ACCESSION NUMBER: 0001493152-22-015263 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220304 FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blosser Wendy E CENTRAL INDEX KEY: 0001927379 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56257 FILM NUMBER: 22973580 MAIL ADDRESS: STREET 1: 5 PENN PLAZA 19TH FLOOR STREET 2: #1954 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Accustem Sciences Inc. CENTRAL INDEX KEY: 0001850767 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA, 19TH FLOOR STREET 2: #1954 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 442070661000 MAIL ADDRESS: STREET 1: 5 PENN PLAZA, 19TH FLOOR STREET 2: #1954 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: AccuStem Sciences Ltd DATE OF NAME CHANGE: 20210311 3 1 ownership.xml X0206 3 2022-03-04 0 0001850767 Accustem Sciences Inc. ACUT 0001927379 Blosser Wendy E 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001 1 1 0 0 Chief Executive Officer Common Stock 2000 D Options (right to buy) 2.13 2032-01-25 Common Stock 490000 D 49,000 of the options vest on January 25, 2023, 2024 and 2025 and 98,000 vest on January 25, 2026. 122,500 options vest upon the closing of a single equity raise netting not less than $30m for the Company; and 122,500 options vest upon the opening of a commercial CLIA lab in the U.S. no later than the fourth quarter 2023. /s/ Wendy Blosser 2022-05-27